| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 12.728 | 20.723 | 27.755 | 27.841 | 27.661 | - |
| Total Income - EUR | - | - | - | - | 12.728 | 20.723 | 27.755 | 27.841 | 27.661 | - |
| Total Expenses - EUR | - | - | - | - | 541 | 7.977 | 15.707 | 15.756 | 26.782 | - |
| Gross Profit/Loss - EUR | - | - | - | - | 12.187 | 12.746 | 12.048 | 12.085 | 879 | - |
| Net Profit/Loss - EUR | - | - | - | - | 11.805 | 12.125 | 11.215 | 11.250 | 538 | - |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | - |
Check the financial reports for the company - Epimedoptica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 2.490 | 8.708 | 8.515 | 8.542 | 13.544 | - |
| Current Assets | - | - | - | - | 9.606 | 15.223 | 2.920 | 2.929 | 15.780 | - |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | - | - | - | - | 9.454 | 13.776 | 1.858 | 1.864 | 13.471 | - |
| Cash | - | - | - | - | 152 | 1.447 | 1.062 | 1.065 | 2.309 | - |
| Shareholders Funds | - | - | - | - | 11.847 | 23.747 | 11.256 | 11.291 | 29.325 | - |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | - | 249 | 184 | 180 | 180 | 0 | - |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Epimedoptica S.r.l.